Laxminarain Prattipati
Transaction: 04/01/2026
BUY
Change
+10,000
Price
$2.37
Filing
04/03/2026
Type
BUY
Microbot Medical Inc.
MBOT • Medical - Instruments & Supplies
$1.44
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$96.72M
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.01Healthy liquidity · 23.33Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:21 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.44
Change0.00%
Shares Out67.16M
Market Cap$96.72M
Enterprise Value$30.22M
52W Range1.60 - 4.67
Beta1.05
P/E-9.53
P/S279.52
P/B1.40
P/FCF-5.39
EV/Sales87.35
Price$1.44
Change0.00%
Shares Out67.16M
Market Cap$96.72M
Enterprise Value$30.22M
52W Range1.60 - 4.67
Beta1.05
P/E-9.53
P/S279.52
P/B1.40
P/FCF-5.39
EV/Sales87.35
EV/EBITDA-1.64
EV/FCF-1.69
Earnings Yield-10.50%
FCF Yield-18.54%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.01
Current Ratio23.33
Quick Ratio23.16
Revenue 5Y-100.00%
Target$4.00
Target Upside177.78%
Target Median$4.00
Target Range4.00 - 4.00
Volume418.89K
Avg Volume1.23M
EPS Surprise0.03
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
93/100
Why this score▼
Manageable debt level · 0.01Healthy liquidity · 23.33Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 4 analyst votes · 2026-09-05
88/100
Bullish
Bullish
3
Hold
1
Bearish
0
Price Target
2026-08-13
Low
$4.00
Mean
$4.00
Median
$4.00
High
$4.00
Insider Transactions
Recent executive and insider activity
Burell Scott R
Transaction: 04/01/2026
BUY
Change
+10,000
Price
$2.37
Filing
04/03/2026
Type
BUY
Wilson David James
Transaction: 04/01/2026
BUY
Change
+10,000
Price
$2.37
Filing
04/03/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Laxminarain Prattipati | BUY | +10,000 | $2.37 | 04/01/2026 | 04/03/2026 |
| Burell Scott R | BUY | +10,000 | $2.37 | 04/01/2026 | 04/03/2026 |
| Wilson David James | BUY | +10,000 | $2.37 | 04/01/2026 | 04/03/2026 |
| Wenderow Tal Baruch | BUY | +10,000 | $2.37 | 04/01/2026 | 04/03/2026 |
| Madden Martin J. | BUY | +10,000 | $2.37 | 04/01/2026 | 04/03/2026 |
| Stockburger Aileen Ptucha | BUY | +10,000 | $2.37 | 04/01/2026 | 04/03/2026 |
| Vaknin Rachel | BUY | +105,000 | $2.10 | 02/18/2026 | 02/20/2026 |
| Sharon Simon | BUY | +105,000 | $2.10 | 02/18/2026 | 02/20/2026 |
| Diaz-Cartelle Juan | BUY | +105,000 | $2.10 | 02/18/2026 | 02/20/2026 |
| Gadot Harel | BUY | +480,000 | $2.10 | 02/18/2026 | 02/20/2026 |
| Diaz-Cartelle Juan | BUY | +42,000 | $2.04 | 02/05/2025 | 02/07/2025 |
| Sharon Simon | BUY | +43,750 | $2.04 | 02/05/2025 | 02/07/2025 |
| Gadot Harel | BUY | +228,000 | $2.04 | 02/05/2025 | 02/07/2025 |
| Vaknin Rachel | BUY | +48,125 | $2.04 | 02/05/2025 | 02/07/2025 |
| Diaz-Cartelle Juan | BUY | +10,500 | $1.25 | 02/26/2024 | 02/07/2025 |
| Sharon Simon | BUY | +8,750 | $1.25 | 02/26/2024 | 02/07/2025 |
| Gadot Harel | BUY | +12,000 | $1.25 | 02/26/2024 | 02/07/2025 |
| Vaknin Rachel | BUY | +4,375 | $1.25 | 02/26/2024 | 02/07/2025 |
| Laxminarain Prattipati | BUY | +10,000 | $1.93 | 01/28/2025 | 01/30/2025 |
| Stockburger Aileen Ptucha | BUY | +10,000 | $1.93 | 01/28/2025 | 01/30/2025 |